In our study, we observed a significant decrease in GPX4 protein levels in ORes-treated breast cancer cells and tissues compared to that in controls, suggesting that ORes-induced ferroptosis is mediated by the inhibition of GPX4. Here, GPX4 is linked to breast cancer.